Abivax (AAVXF) Goodwill & Intangibles (2021 - 2026)
Abivax (AAVXF) posted Goodwill & Intangibles of $29.3 million for Q1 2026, up 0.58% on a QoQ basis from $29.1 million in Q4 2025, and up 11.3% year-over-year from $26.3 million in Q1 2025.
Analysis
Abivax (AAVXF) Goodwill & Intangibles (2021 - 2026) Analysis & Trends
Abivax has reported Goodwill & Intangibles for 6 years, with the latest figure at $29.3 million in Q1 2026.
- On a quarterly basis, Goodwill & Intangibles rose 11.3% year-over-year to $29.3 million in Q1 2026; TTM through Mar 2026 was $29.3 million, a 11.3% increase from a year earlier, with the FY2025 full-year figure at $29.1 million, up 8.93% from the prior year.
- Goodwill & Intangibles was $29.3 million for Q1 2026 at Abivax, up from $29.1 million in the prior quarter.
- The five-year high for Goodwill & Intangibles was $29.3 million in Q1 2026, with the low at $25.5 million in Q4 2022.
- Average Goodwill & Intangibles over 5 years is $27.6 million, with a median of $27.0 million recorded in 2024.
- The sharpest annual moves came in 2022 and 2026: Goodwill & Intangibles slumped 30.46% in 2022, then increased 11.3% in 2026.
- Over 5 years, Goodwill & Intangibles stood at $25.5 million in 2022, then grew by 5.45% to $26.9 million in 2023, then fell by 0.67% to $26.7 million in 2024, then gained by 8.93% to $29.1 million in 2025, then advanced by 0.58% to $29.3 million in 2026.
- The last three Goodwill & Intangibles figures came in at $29.3 million (Q1 2026), $29.1 million (Q4 2025), and $29.3 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.37 Bn | 197.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 181.12 Bn | 177.94 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.11 Bn | 124.26 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.51 Bn | 74.52 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.69 Bn | 56.50 Bn | 1.37 Bn |
| 6 | Moderna | 54.62 Bn | 49.48 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.14 Bn | 30.84 Bn | 992.69 Mn |
| 8 | Biogen | 31.29 Bn | 30.01 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.09 Bn | 30.09 Bn | 1.16 Mn |
| 10 | Abivax | 10.92 Bn | 10.92 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 29.30 Mn |
| Dec 31, 2025 | 29.13 Mn |
| Sep 30, 2025 | 29.26 Mn |
| Jun 30, 2025 | 28.33 Mn |
| Mar 31, 2025 | 26.32 Mn |
| Dec 31, 2024 | 26.74 Mn |
| Jun 30, 2024 | 26.95 Mn |
| Dec 31, 2023 | 26.92 Mn |
| Dec 31, 2022 | 25.53 Mn |
| Dec 31, 2021 | 36.72 Mn |